Villere ST Denis J & Co. LLC Trims Stock Position in Option Care Health, Inc. $OPCH

Villere ST Denis J & Co. LLC cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 3.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 801,040 shares of the company’s stock after selling 30,085 shares during the period. Option Care Health accounts for about 2.4% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 23rd largest holding. Villere ST Denis J & Co. LLC owned approximately 0.51% of Option Care Health worth $21,564,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health in the 4th quarter valued at $25,000. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the 2nd quarter worth about $37,000. Advisory Services Network LLC acquired a new stake in shares of Option Care Health during the 3rd quarter worth about $35,000. Caitong International Asset Management Co. Ltd purchased a new stake in Option Care Health in the 3rd quarter valued at about $38,000. Finally, Employees Retirement System of Texas purchased a new stake in Option Care Health in the 4th quarter valued at about $45,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Buying and Selling

In other Option Care Health news, Director Timothy P. Sullivan bought 24,154 shares of Option Care Health stock in a transaction on Thursday, May 7th. The shares were bought at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the acquisition, the director directly owned 73,383 shares in the company, valued at $1,518,294.27. This represents a 49.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO John Charles Rademacher bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares of the company’s stock, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 73,264 shares of company stock valued at $1,548,316 in the last ninety days. Company insiders own 1.70% of the company’s stock.

Option Care Health Trading Down 0.5%

Option Care Health stock traded down $0.10 during midday trading on Friday, reaching $21.57. 1,803,038 shares of the stock traded hands, compared to its average volume of 2,424,430. The company has a 50-day simple moving average of $21.03 and a two-hundred day simple moving average of $27.87. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80. The firm has a market cap of $3.39 billion, a PE ratio of 16.72, a price-to-earnings-growth ratio of 1.20 and a beta of 0.65. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts expect that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Truist Financial set a $30.00 target price on shares of Option Care Health in a research note on Friday, May 1st. Weiss Ratings downgraded shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective on the stock. in a report on Friday, May 1st. Stephens set a $30.00 price objective on shares of Option Care Health in a research report on Friday, May 1st. Finally, Morgan Stanley set a $28.00 target price on shares of Option Care Health in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.